Prelude Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,948
| Closed | -$37K | – | 783 |
|
|
2020
Q3 | $37K | Sell |
1,948
-241
| -11% | -$4.58K | ﹤0.01% | 913 |
|
|
2020
Q2 | $49K | Buy |
+2,189
| New | +$49K | ﹤0.01% | 808 |
|
|
2019
Q4 | – | Sell |
-2,435
| Closed | -$48K | – | 1388 |
|
|
2019
Q3 | $48K | Sell |
2,435
-3,500
| -59% | -$69K | ﹤0.01% | 759 |
|
|
2019
Q2 | $125K | Sell |
5,935
-3,000
| -34% | -$63.2K | 0.01% | 581 |
|
|
2019
Q1 | $183K | Buy |
8,935
+5,388
| +152% | +$110K | 0.01% | 471 |
|
|
2018
Q4 | $71K | Buy |
+3,547
| New | +$71K | ﹤0.01% | 752 |
|
|
2018
Q2 | – | Sell |
-1,750
| Closed | -$33K | – | 1351 |
|
|
2018
Q1 | $33K | Buy |
+1,750
| New | +$33K | ﹤0.01% | 1043 |
|
|
2017
Q2 | – | Sell |
-2,326
| Closed | -$34K | – | 1459 |
|
|
2017
Q1 | $34K | Sell |
2,326
-7,943
| -77% | -$116K | ﹤0.01% | 1088 |
|
|
2016
Q4 | $189K | Sell |
10,269
-17,449
| -63% | -$321K | 0.02% | 567 |
|
|
2016
Q3 | $526K | Buy |
27,718
+6,640
| +32% | +$126K | 0.06% | 268 |
|
|
2016
Q2 | $340K | Buy |
21,078
+2,000
| +10% | +$32.3K | 0.05% | 327 |
|
|
2016
Q1 | $229K | Sell |
19,078
-7,400
| -28% | -$88.8K | 0.03% | 448 |
|
|
2015
Q4 | $377K | Buy |
26,478
+5,400
| +26% | +$76.9K | 0.06% | 312 |
|
|
2015
Q3 | $246K | Buy |
+21,078
| New | +$246K | 0.04% | 443 |
|